DERMATA THERAPEUTICS, INC.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
424B3 Feb 5, 2025 424B3
D/A Feb 4, 2025
CORRESP Feb 3, 2025
UPLOAD Feb 3, 2025
S-3 Jan 30, 2025 S-3
SCHEDULE 13G Jan 28, 2025
D Jan 28, 2025
SCHEDULE 13D/A Jan 23, 2025
4 Jan 23, 2025 FORM 4
4 Jan 23, 2025 PRIMARY DOCUMENT
4 Jan 23, 2025 PRIMARY DOCUMENT
4 Jan 23, 2025 PRIMARY DOCUMENT
8-K Jan 23, 2025 FORM 8-K
8-K Jan 21, 2025 FORM 8-K
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 FORM 4
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 FORM 4
← Newer Page 5 of 15 · 366 filings Older →